Clinton Group’s Edwards Lifesciences EW Stock Holding History

Clinton Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-69,453	Closed	-$2.53M	–	432
2017 Q3	$2.53M	Buy	69,453 +12,915	+23%	+$493K	0.28%	114
2017 Q2	$2.23M	Buy	56,538 +7,833	+16%	+$286K	0.23%	142
2017 Q1	$1.53M	Sell	48,705 -25,224	-34%	-$790K	0.09%	318
2016 Q4	$2.31M	Buy	+73,929	New	+$2.4M	0.13%	217
2016 Q3	–	Sell	-119,388	Closed	-$3.97M	–	950
2016 Q2	$3.97M	Buy	119,388 +91,608	+330%	+$3.13M	0.17%	164
2016 Q1	$817K	Sell	27,780 -102,645	-79%	-$2.83M	0.05%	475
2015 Q4	$3.43M	Buy	+130,425	New	+$3.39M	0.28%	101
2015 Q3	–	Sell	-12,618	Closed	-$300K	–	719
2015 Q2	$300K	Buy	+12,618	New	+$285K	0.04%	474
2014 Q4	–	Sell	-27,030	Closed	-$460K	–	497
2014 Q3	$460K	Buy	+27,030	New	+$427K	0.19%	192
2013 Q4	–	Sell	-71,922	Closed	-$835K	–	337
2013 Q3	$835K	Buy	+71,922	New	+$841K	0.25%	84

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Clinton Group's EW Position: Q4 2017 in Review

Clinton Group sold out of Edwards Lifesciences (EW) in Q4 2017, closing a stake of 69,453 shares — an estimated $2.53M sold.

Clinton Group first reported a position in EW in Q3 2013 and held it in 10 quarters. The position peaked at $3.97M in Q2 2016. 773 funds tracked by Wall St. Rank hold EW as of Q4 2017.

Clinton Group reported no remaining Edwards Lifesciences position as of Q4 2017 after selling out during the quarter.
Clinton Group sold 69,453 Edwards Lifesciences shares in Q4 2017, an estimated $2.53M.
Clinton Group first reported a position in Edwards Lifesciences in Q3 2013 and held it in 10 quarters.
Clinton Group's Edwards Lifesciences position peaked at $3.97M in Q2 2016.
773 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2017.

Based on Clinton Group's 13F filing for Q4 2017, filed 14 Feb 2018.